Israel Chemicals (ICL) Raised to “Hold” at Zacks Investment Research

Israel Chemicals (NYSE:ICL) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Wednesday, September 12th.

According to Zacks, “Israel Chemicals Ltd. is a manufacturer of specialty fertilizers and specialty phosphates, flame retardants and water treatment solutions. It operates primarily in three markets: agriculture, food and engineered materials. The Company’s products include bromine specialty chemicals, potash, phosphate fertilizers, and specialty performance and industrial products. It markets its products primarily in Israel, Europe, and the Americas. Israel Chemicals Ltd. is headquartered in Tel Aviv, Israel. “

Separately, ValuEngine upgraded shares of Israel Chemicals from a “hold” rating to a “buy” rating in a research report on Friday, August 24th. Two research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $5.25.

NYSE ICL traded down $0.01 during mid-day trading on Wednesday, reaching $6.22. 110,388 shares of the stock were exchanged, compared to its average volume of 241,686. Israel Chemicals has a 1 year low of $3.85 and a 1 year high of $6.90. The company has a market capitalization of $7.86 billion, a PE ratio of 20.06 and a beta of 1.14. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.76 and a current ratio of 1.35.

Israel Chemicals (NYSE:ICL) last posted its quarterly earnings data on Wednesday, August 1st. The basic materials company reported $0.09 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.08 by $0.01. The business had revenue of $1.37 billion for the quarter. Israel Chemicals had a net margin of 22.74% and a return on equity of 14.16%. The business’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same period in the previous year, the business earned $0.05 earnings per share. On average, equities analysts expect that Israel Chemicals will post 0.36 EPS for the current year.

Institutional investors and hedge funds have recently made changes to their positions in the business. Stifel Financial Corp increased its position in shares of Israel Chemicals by 276.8% during the first quarter. Stifel Financial Corp now owns 45,338 shares of the basic materials company’s stock valued at $185,000 after acquiring an additional 33,305 shares during the last quarter. Eqis Capital Management Inc. purchased a new position in shares of Israel Chemicals in the second quarter valued at approximately $245,000. A.R.T. Advisors LLC boosted its stake in shares of Israel Chemicals by 147.4% in the first quarter. A.R.T. Advisors LLC now owns 59,138 shares of the basic materials company’s stock valued at $250,000 after purchasing an additional 35,230 shares during the period. BlackRock Inc. boosted its stake in shares of Israel Chemicals by 13.9% in the first quarter. BlackRock Inc. now owns 113,993 shares of the basic materials company’s stock valued at $483,000 after purchasing an additional 13,942 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Israel Chemicals by 29.9% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 144,534 shares of the basic materials company’s stock valued at $659,000 after purchasing an additional 33,274 shares during the period. Institutional investors and hedge funds own 8.11% of the company’s stock.

Israel Chemicals Company Profile

Israel Chemicals Ltd. operates as a specialty minerals company worldwide. The company operates through two segments, Essential Minerals and Specialty Solutions. The company extracts potash from the Dead Sea; mines and produces potash, salt, and Polysulphate; and produces, markets, and sells pure magnesium and magnesium alloys, as well as produces dry carnallite and related by-products, including chlorine and sylvinite.

Featured Article: Initial Public Offering (IPO)

Get a free copy of the Zacks research report on Israel Chemicals (ICL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply